Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients
A trial of lixisenatide to assess its effects in early Parkinson’s disease.
https://www.news-medical.net/n....ews/20240418/Phase-2
Discover the world at Altruu, The Discovery Engine